JAKing up immunity
- PMID: 38900897
- DOI: 10.1126/science.adq1717
JAKing up immunity
Abstract
Janus kinase (JAK) inhibitors improve antitumor responses.
Comment on
-
Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients.Science. 2024 Jun 21;384(6702):eadf1329. doi: 10.1126/science.adf1329. Epub 2024 Jun 21. Science. 2024. PMID: 38900877 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
